- Article
- Source: Campus Sanofi
Diagnosis and Misdiagnosis of MPS I

Common Misdiagnosis
Those working outside of specialist treatment centres come across MPS I infrequently, therefore the index of suspicion is low.1,2 Moreover, due to its variable time of onset, severity and phenotype, MPS I is frequently misdiagnosed and under-diagnosed, which leads to many referrals between specialities.2 MPS I patients see an average of 5 specialists and wait for approximately 3 years before receiving an accurate diagnosis.2
With some symptoms more easily recognised by particular specialists, collaboration amongst specialties can help to connect the different symptoms and hasten the diagnosis.1,
Patients with MPS I may share symptoms with many other, often more common diseases.4 Paediatricians are in a good position to recognise the red flags of MPS I as they are able to review the medical history of patients who make repeat visits for common childhood complaints.5
Common Misdiagnosis of MPS I
- Autoimmune disease
- Rheumatoid arthritis
- Juvenile idiopathic arthritis and Spondyloarthritis
- Connective tissue disease
- Scleroderma
- Growing pains
- Other systemic rheumatic disorders
- Fibromyalgia
- Polynephropathy
- Muscular dystrophy
- Polymyositis
- Dermatomyositis
- Legg-Perthes disease
- Osteogenis imperfecta
Adapted from Hendriksz c 20111
If you suspect MPS I, don’t wait – diagnostic testing should be done without delay.1
Minimise time-to-treatment to potentially slow or prevent development of irreversible conditions that profoundly affect quality of life.3
Diagnosis
Clinician/Metabolic specialist
Diagnosis is made by urinary glycosaminoglycan (uGAG) analysis and confirmed by a molecular genetic test.
Treatment
MPS I treatment
Optimal care involves both support and disease-specific treatment and regular follow up with a multidisciplinary team experienced in the management of MPS. Disease specific therapies include enzyme replacement and haemotopoietic stem cell transplantation.
Adapted from Muenzer et al 2009.3
All patients with suspected MPS should undergo a urinary glycosaminoglycan (uGAG) analysis.1,6
If the test shows abnormally high levels of GAGs, the patient should be referred to a metabolic specialist for a definitive diagnosis of MPS I.1,6
Referral to a geneticist for molecular testing identifies mutations and abnormalities in gene coding for the enzyme. Molecular testing is primarily used to confirm the diagnosis of MPS type.6
MPS I should be managed by a multidisciplinary team with comprehensive follow up.1,7
Surgical Connection
MPS I is often difficult to diagnose because of the nonspecific nature of its early symptoms.8 Additionally, children with MPS I have a high number of surgeries that are common in childhood, with most having several apparently unrelated operations in early childhood before they receive a diagnosis.9
Hernia Repair
Inguinal operations are often performed in older children with MPS I (over the age of 1) compared with the general population (under 1 year of age).9 They are usually associated with increased intra-abdominal pressure, hepatosplenomegaly, and weakened muscle and connective tissue, which frequently occur in early MPS I.9
Orthopaedic Conditions
Many children with MPS I have skeletal deformities that require evaluation and surgery.3,7 Among the most common are: spinal deformities, spinal cord compression, joint stiffness, joint contractures, arthropathy, hip dysplasia, knock-knees, claw deformity, carpal tunnel syndrome, and trigger digits.3,7
Ear, Nose and Throat procedures
Myringotomies, adenoidectomy, and tonsillectomy are the most common surgeries in all children.9 Around a third of children with MPS I require these procedures, which tend to occur at an earlier age (around 3 years) compared with the general population (around 7 years).9
Carpel Tunnel Syndrome
MPS is one of the most common causes of carpal tunnel syndrome in children and adolescents.7,9 Carpal tunnel syndrome is one of the top five surgeries in MPS I, being particularly frequent in attenuated forms.9
Suspect
- Don’t wait to piece together MPS I. If you see signs and symptoms indicative of MPS I, request a urinary GAG analysis.
Test
- A simple uGAG test is the first step in diagnosing MPS I.6 Most patients with the disease will show increased urinary secretion of GAGs (note, this assay is not 100% sensitive).6,7
Refer
- If the uGAG test result shows abnormally high levels of GAGs, or a uGAG test is not available but signs and symptoms indicate MPS I, the patient should be referred to a metabolic specialist at a specialist treatment centre for a definitive diagnosis.1,7
- Hendriksz C. Br J Hosp Med. 2011;72:91–95.
- Bruni S et al. Mol Genet Metab Rep. 2016;8:67–73.
- Muenzer J et al. Pediatrics. 2009;123:19–29.
- Clarke LA et al. J Pediatr 2017;182:363–369.
- D'Aco K et al. Eur J Pediatr. 2012;171:911–919.
- Lehman TJA et al. Rheumatology (Oxford). 2011;50 Suppl5:v41–v48.
- Cimaz R et al. Pediatr Rheumatol Online J. 2009;7:18.
- Beck M et al. Genet Med. 2014;16:759–765.
- Arn P et al. J Pediatr. 2009;154:859–864.